Synapse - Genitourinary Oncology Service

Search Within

Genitourinary Oncology Service

Results (5696)

Update on systemic prostate cancer therapies: Management of metastatic castration-resistant prostate cancer in the era of precision oncology

Review

Nuhn, P.; De Bono, J. S.; Fizazi, K.; Freedland, S. J.; Grilli, M.; Kantoff, P. W.; Sonpavde, G.; Sternberg, C. N.; Yegnasubramanian, S.; Antonarakis, E. S.
European Urology (2019)

Fulltext@MSK | Save

Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy

Editorial

Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
European Urology (2019)

Fulltext@MSK | Save

Development of a prediction tool for exclusive locoregional recurrence after radical cystectomy in patients with muscle-invasive bladder cancer

Journal Article

Necchi, A.; Pond, G. R.; Moschini, M.; Plimack, E. R.; Niegisch, G.; Yu, E. Y.; Bamias, A.; Agarwal, N.; Vaishampayan, U.; Theodore, C.; more...
Clinical Genitourinary Cancer (2019)

Fulltext@MSK | Save

Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma

Guidelines

Msaouel, P.; Hong, A. L.; Mullen, E. A.; Atkins, M. B.; Walker, C. L.; Lee, C. H.; Carden, M. A.; Genovese, G.; Linehan, W. M.; Rao, P.; more...
Clinical Genitourinary Cancer (2019)

Fulltext@MSK | Save

Circulating tumor cells in prostate cancer: From discovery to clinical utility

Review

Pantel, K.; Hille, C.; Scher, H. I.
Clinical Chemistry (2019)

Fulltext@MSK | Save

Lobular carcinomas in situ display intralesion genetic heterogeneity and clonal evolution in the progression to invasive lobular carcinoma

Journal Article

Lee, J. Y.; Schizas, M.; Geyer, F. C.; Selenica, P.; Piscuoglio, S.; Sakr, R. A.; Ng, C. K. Y.; Carniello, J. V. S.; Towers, R.; Giri, D. D.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

PTEN expression, not mutation status in TSC1, TSC2, or mTOR, correlates with the outcome on everolimus in patients with renal cell carcinoma treated on the randomized RECORD-3 trial

Journal Article

Voss, M. H.; Chen, D.; Reising, A.; Marker, M.; Shi, J.; Xu, J.; Ostrovnaya, I.; Seshan, V. E.; Redzematovic, A.; Chen, Y. B.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations

Journal Article

Manley, B. J.; Reznik, E.; Ghanaat, M.; Kashan, M.; Becerra, M. F.; Casuscelli, J.; Tennenbaum, D.; Redzematovic, A.; Carlo, M. I.; Sato, Y.; more...
Urologic Oncology: Seminars and Original Investigations (2019)

Fulltext@MSK | Save

Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survival

Journal Article

Xie, W.; Stopsack, K. H.; Drouin, S. J.; Fu, H.; Pomerantz, M. M.; Mucci, L. A.; Lee, G. S. M.; Kantoff, P. W.
Prostate (2019)

Fulltext@MSK | Save

Systemic treatment of metastatic clear cell renal cell carcinoma in 2018: Current paradigms, use of immunotherapy, and future directions

Review

Lalani, A. K. A.; McGregor, B. A.; Albiges, L.; Choueiri, T. K.; Motzer, R.; Powles, T.; Wood, C.; Bex, A.
European Urology (2019)

Fulltext@MSK | Save